Trial intelligence / Profile preview

Comparison of Ziferon and Betaferon in multiple sclerosis management

IRCT138806102397N1Phase 3Completed

Sponsor
Medical Vice chancellor for research, Tehran University of Science
Start
Sep 2010
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Medical Vice chancellor for research, Tehran University of Science. Started Sep 2010; status: completed.

02

Drugs

interferon beta-1a
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on IRCT138806102397N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138806102397N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call